Meloxicam: A review of its pharmacokinetics, efficacy and tolerability following intramuscular administration

Inflammation Research

Volumn 50, Issue SUPPL. 1, 2001, Pages

  Euller Ziegler, L ^a   Velicitat, P ^b   Bluhmki, E ^c   Turck D ^c   Scheuerer, S ^c   Combe, B ^d  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b BOEHRINGER INGELHEIM   (France)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d LAPEYRONIE HOSPITAL   (France)

Author keywords

Intramuscular; Meloxicam; Non steroidal anti inflammatory drugs; Rheumatoid arthritis

Indexed keywords

CREATINE KINASE; DICLOFENAC; MELOXICAM; PIROXICAM;

ACUTE DISEASE; ADULT; ARTHRITIS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; INFLAMMATION; ISCHIALGIA; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; REVIEW; RHEUMATIC DISEASE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; HUMANS; INJECTIONS, INTRAMUSCULAR; THIAZINES; THIAZOLES;

EID: 0035088395     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Intramuscular use of NSAIDs
2. Elevated serum CPK after drug injections
3. Local and systemic tolerability of piroxicam after intramuscular administration in healthy volunteers
4. Review of clinical trials and benefit/risk ratio of meloxicam
5. Safety of meloxicam: A global analysis of clinical trials
6. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the Safety and Efficacy Large Scale Evaluation of COX inhibiting Therapies (SELECT) trial in osteoarthritis
7. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients
8. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2
9. Pharmacological, pharmacokinetic and clinical profile of meloxicam
10. Local tissue tolerability of meloxicam, a new NSAID: Indications for parenteral, dermal and mucosal administration
11. Pharmacokinetics and tolerability of meloxicam after im administration
12. A review of the clinical pharmacokinetics of meloxicam
13. Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica
14. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: A comparison with intramuscular and oral piroxicam
15. Tolerability of multiple administration of intramuscular meloxicam: A comparison with intramuscular piroxicam in patients with rheumatoid arthritis and osteoarthritis
16. A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs
17. The intramuscular formulation of the COX-2 inhibitor meloxicam is effective and safe in osteoarthritis